| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.04B | -0.5% |
| R&D Expense | $70.7M | -36.5% |
| SG&A Expense | $308.0M | -16.4% |
| Operating Income | -$108.7M | +85.0% |
| Pre-tax Income | -$142.9M | +80.5% |
| Income Tax | $47.7M | +62.8% |
| Net Income | -$190.6M | +74.9% |
| EPS (Basic) | -$3.60 | +75.8% |
| EPS (Diluted) | -$3.60 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $99.5M | -10.9% |
| Accounts Receivable | $154.5M | -19.1% |
| Inventory | $311.7M | -5.2% |
| Current Assets | $598.7M | -11.9% |
| Total Assets | $1.39B | -23.8% |
| Current Liabilities | $162.4M | -75.1% |
| Long-term Debt | $700.0M | -19.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $58.7M | +128.5% |
| Capital Expenditures | $22.9M | -55.6% |
| Investing Cash Flow | $125.2M | -41.0% |
| Financing Cash Flow | -$190.0M | +64.5% |
| Free Cash Flow | $35.8M | +113.9% |
| +75.8% |
| Total Liabilities |
| $906.9M |
| -22.7% |
| Stockholders' Equity | $482.8M | -25.6% |